ArticleProceedings of the National Academy of Sciences of the United States of America2020

Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy.

Aadra P Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.